🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$PRTA Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease businesswire.com/news/home/2025…

$SUPN $SAGE Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio $8.50/sh in cash + CVR globenewswire.com/news-release/2…

You can read the story from Jason Mast and me here: statnews.com/2025/06/16/duc…

ELI LILLY IS IN ADVANCED TALKS TO BUY GENE EDITING START-UP VERVE THERAPEUTICS FOR UP TO $1.3BN - FT $LLY $VERV

Today, we are thrilled to announce that Verve Therapeutics has entered into a definitive agreement to be acquired by Eli Lilly and Company From 2018 to 2025, Verve moved a new concept (a one-dose future for the treatment of atherosclerotic cardiovascular disease) and a new medical technology (in

$MLYS Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria globenewswire.com/news-release/2…

sec.gov/Archives/edgar…

Is there a reason this needed to be halted?

$ARVN Great catch: sec.gov/Archives/edgar…

$CAPR follow up: Spokesperson tells me the company is still trying to figure out from the FDA whether the adcomm scheduled for July 30 is still happening, or not. Strange.

$CRDF Just an incredible amount of confidence-building in this PR Swapping CMO, about a month before data. And a little birdie noted this new hire has an interesting past: www2.mbc.ca.gov/BreezePDL/docu… investors.cardiffoncology.com/news-releases/…

$SRRK Scholar Rock Reports Positive Phase 2 EMBRAZE Trial Results Demonstrating Statistically Significant Preservation of Lean Mass with Apitegromab During Tirzepatide-Induced Weight Loss businesswire.com/news/home/2025…